Sponsor study identifier
observational
200
0 countries
N/A
Study Start
July 2006
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 2009
Actual (reported)Study Completion
December 2010
Actual (reported)The purpose of this study is to evaluate topographic features of the posterior pole of the eye in normal subjects as well as in subjects with diabetes mellitus but without diabetic retinopathy (DR) using optical coherence tomography (OCT). The investigators proposal is a novel study to determine retinal volume of normal and diabetic subjects without DR. Specifically, the investigators will establish a standardized reference range for retinal thickness and volume that will provide standards for OCT analysis of different clinical trials for retinal diseases.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2010
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 2006
Date type not reportedThis date has not been verified as actual or estimated.
November 2009
Actual (reported)December 2010
Actual (reported)September 17, 2013
Actual (reported)September 20, 2013
Actual (reported)Normative retinal thickness data for comparison
Normative retinal thickness data for comparison
one year
Normal retina
Diabetic patients without diabetic retinopathy
Images taken to determine thickness values in the retina
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Normal, non-diabetic patients
Quan D Nguyen, MD, MSc
Johns Hopkins University
200 participants (actual enrollment reported by the registry).
First Submitted
September 17, 2013
First Posted
September 20, 2013
Study Start
July 2006
Date type not reportedThis date has not been verified as actual or estimated.
Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
Contact the study team to confirm eligibility.
Primary Completion
November 2009
Actual (reported)Study Completion
December 2010
Actual (reported)Last Updated
December 6, 2017
Record last verified: 2017-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: